AgomAb Therapeutics NV Stock Price, News & Analysis
Company Description
AgomAb Therapeutics NV (NASDAQ: AGMB) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $602.9M, ranking #3,323 among all listed U.S. companies by market cap.
AGMB stock has declined 12.2% over the past year. Shares last traded at $11.64.
This page provides a comprehensive overview of AGMB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AgomAb Therapeutics NV (AGMB) stock last traded at $11.64, up 9.06% from the previous close. Over the past 12 months, the stock has lost 12.2%. At a market capitalization of $602.9M, AGMB is classified as a small-cap stock with approximately 48.7M shares outstanding.
Latest News
AgomAb Therapeutics NV has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include IPO, offering. View all AGMB news →
SEC Filings
AgomAb Therapeutics NV has filed 5 recent SEC filings, including 5 Form 3. The most recent filing was submitted on March 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all AGMB SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AGMB Company Profile & Sector Positioning
AgomAb Therapeutics NV (AGMB) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.